Tina S. Nova, Ph.D.
Tina S. Nova, Ph.D. is currently the President and CEO of a newly formed molecular diagnostic company, Molecular Stethoscope, Inc. The company is focused on circulating RNA which can be utilized for the assessment of specific organ health and disease. Most recently, she was the SVP and GM of Illumina’s Oncology Business Unit. From 2000 to 2014, she was Co-Founder & Director and President & CEO of Genoptix Medical Laboratory, which was purchased by Novartis Pharmaceuticals for close to $0.5B in 2011. She also held senior positions at Nanogen, Ligand Pharmaceuticals and Hybritech, Inc.